To estimate the frequency of aberrant MNX1 expression in AML cases, we performed an unbiased qRT-PCR screen of three different AML cohorts (Rotterdam, Ulm, and Jena; Fig. 5A). The gene discussed is MNX1; the disease is acute myeloid leukemia.